(Total Views: 517)
Posted On: 01/26/2022 2:07:10 PM
Post# of 145247
CDiddy,
Leronlimab blocks ccr5, blocking immune hyperactivation which persists in Omicron or we would it be witnessing 2,000+ deaths daily in the US.
Covid, influenza, Ebola all follow similar pathways, addressable by Leronlimab. The symptoms may vary, but the underlying immune activation shares a common pathway.
Covid is the first acute infection addressed by Leronlimab. It won’t be the last.
Leronlimab blocks ccr5, blocking immune hyperactivation which persists in Omicron or we would it be witnessing 2,000+ deaths daily in the US.
Covid, influenza, Ebola all follow similar pathways, addressable by Leronlimab. The symptoms may vary, but the underlying immune activation shares a common pathway.
Covid is the first acute infection addressed by Leronlimab. It won’t be the last.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)